News Sentiment

OPK sentiment intelligence

Opko Health Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 51 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Diagnostics & Research Read-through group
Latest close 1.35 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 51

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-11.2% over one week, -4.9% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

OPK5733212 Bond Profile — Key Metrics

Market Reaction

Price moving ahead of tone

58/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction -11.2% Price reacting lower
Trend fit Trend active -4.9% over four weeks
Fair value -3.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 11
Neutral 36
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 51
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 14
TradingView 11
Stock Titan 6
simplywall.st 4
Ad-hoc-news.de 3
OPKO Health, Inc. 2
MarketBeat 1
Quartr 1

Event Lens

What the news is about

Classified themes
Market update 26
Earnings 18
Deals and strategy 5
Macro sensitivity 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 51
TradingView Direct company coverage

OPK5733212 Bond Profile — Key Metrics

This article provides key metrics for the OPK5733212 bond issued by OPKO Health, Inc. The bond has a 3.75% coupon rate, was issued on January 9, 2024, and matures on January 15, 2029, with a face value of $1,000. OPKO Health, Inc. is described as a biopharmaceutical and diagnosti

Tone
Neutral 50/100
Event
Market update
Published
15 Jul 2026 02:11
Source
TradingView
MarketBeat Direct company coverage

Zacks Research Has Weak Estimate for OPKO Health Q2 Earnings

Zacks Research has reduced its Q2 2028 EPS estimate for OPKO Health (NASDAQ:OPK) to -$0.05 from -$0.04, reflecting a weaker outlook, though the full-year estimate remains at -$0.29 per share. This follows the company's recent quarterly results where EPS matched expectations at -$

Tone
Negative 29/100
Event
Earnings
Published
13 Jul 2026 05:39
Source
MarketBeat
TradingView Direct company coverage

ETFs Investing in OPKO Health, Inc. Stocks

This article lists various ETFs that invest in OPKO Health, Inc. stocks. It provides a detailed table including each ETF's market value, weight of OPKO in its holdings, issuer, management style, expense ratio, AUM, price, and 3-year NAV total return. The ETFs cover different inve

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 20:10
Source
TradingView
Quartr Direct company coverage

OPKO Health (OPK) Piper Sandler 36th Annual Healthcare Conference Summary

OPKO Health presented at the Piper Sandler 36th Annual Healthcare Conference, highlighting the growth of its Ngenla human growth hormone, with Pfizer projecting $500 million to $1 billion in near-term sales. The company also discussed its ModeX platform for multispecific antibodi

Tone
Neutral 50/100
Event
Market update
Published
05 Jul 2026 20:10
Source
Quartr
Finviz Direct company coverage

OPK - Opko Health Inc Options

This article provides a comprehensive overview of Opko Health Inc. (OPK) stock, including its latest closing price, key financial metrics, performance indicators, and ownership details. It details statistics such as market capitalization, income, sales, P/E ratio, EPS, insider an

Tone
Neutral 50/100
Event
Earnings
Published
03 Jul 2026 17:40
Source
Finviz
Ad-hoc-news.de Direct company coverage

OPKO Health Inc focuses on diagnostics and pharmaceuticals as investors weigh long-term prospects

OPKO Health Inc is building its business around both diagnostic services and specialty pharmaceutical products. The company aims to diversify its revenue streams and capitalize on growth opportunities in the healthcare sector. Investors are closely monitoring OPKO's strategy for

Tone
Positive 65/100
Event
Earnings
Published
03 Jul 2026 15:10
Source
Ad-hoc-news.de
Investing.com UK Direct company coverage

Form 13D/A OPKO HEALTH For: 1 July By Investing.com

This article announces that OPKO Health has filed a Form 13D/A for July 1st. It also includes general market data, popular news, and various financial statistics. The content itself provides no further details beyond the filing announcement.

Tone
Neutral 50/100
Event
Market update
Published
03 Jul 2026 07:10
Source
Investing.com UK
Stock Titan Direct company coverage

Phillip Frost (NASDAQ: OPK) reports 34.1% beneficial stake in OPKO

Phillip Frost has reported a significant 34.1% beneficial stake in OPKO Health (NASDAQ: OPK), totaling 255,429,406 shares. This ownership includes holdings through Gamma Trust, Frost Nevada Investments Trust, a philanthropic foundation, stock options, and restricted stock units.

Tone
Neutral 50/100
Event
Deals and strategy
Published
01 Jul 2026 19:39
Source
Stock Titan
TradingView Direct company coverage

Enterprise value to EBITDA forward of Opko Health, Inc. – NASDAQ:OPK

This article presents financial data for Opko Health, Inc. (NASDAQ: OPK), specifically focusing on its enterprise value to EBITDA forward metric. The content was sourced from TradingView and includes general company and market information, but the specific financial value for the

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 06:10
Source
TradingView
TradingView Direct company coverage

OPKO Health, Inc. Actuals & Estimates (BMV:OPK)

This article provides an overview of OPKO Health, Inc. (BMV:OPK) stock, including current price, analyst forecasts, historical highs and lows, volatility, market capitalization, and financial reports. It also details recent earnings, revenue, net income, and confirms that the com

Tone
Negative 36/100
Event
Earnings
Published
27 Jun 2026 07:09
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of OPKO Health, Inc. – FWB:XCY

This article provides a financial metric, the "Price to earnings forward," for OPKO Health, Inc. (FWB:XCY) on the TradingView platform. It indicates that the company's financial data is available for review, though no specific values are presented in this snippet. The content pri

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 03:10
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Opko Health, Inc. – NASDAQ:OPK

This page from TradingView displays information related to the forward price-to-sales ratio for Opko Health, Inc. (NASDAQ: OPK). It indicates that the content is a financial data point for the company, accessible through the platform's market data and financial tools. The page it

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 00:09
Source
TradingView
TradingView Direct company coverage

Price to book forward of OPKO Health, Inc. – FWB:XCY

The article focuses on the "Price to book forward" metric for OPKO Health, Inc. (FWB:XCY) listed on the Frankfurt Stock Exchange. It provides financial data context without presenting specific values in the clean content. The page also outlines various features and services offer

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 19:09
Source
TradingView
TradingView Direct company coverage

OPKO Health, Inc. Actuals & Estimates (NASDAQ:OPK)

This article provides an overview of OPKO Health, Inc. (NASDAQ: OPK) stock, including its current price, market capitalization, historical highs and lows, and analyst forecasts. It also details the company's financial actuals and estimates for earnings and revenue, noting that OP

Tone
Positive 63/100
Event
Earnings
Published
26 Jun 2026 11:09
Source
TradingView
TradingView Direct company coverage

XCY Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for OPKO Health, Inc. (XCY) stock based on analyst opinions. It includes details on the company's past performance, earnings, revenue, and other financial metrics. The article also addresses frequently asked questions about XCY, s

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 20:40
Source
TradingView
TradingView Direct company coverage

OPKO Health, Inc. Actuals & Estimates (TASE:OPK)

This article provides an overview of OPKO Health, Inc. (TASE:OPK) stock, including its current price, performance, analyst forecasts, and financial data. It covers historical price movements, market capitalization, earnings reports, revenue, EBITDA, and employee count, alongside

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 18:41
Source
TradingView
TradingView Direct company coverage

OPK Forecast — Price Target — Prediction for 2027

This article provides a detailed forecast and price target for Opko Health, Inc. (OPK) stock for 2027, based on analyst opinions. It includes current stock performance metrics, historical highs and lows, financial data like earnings and revenue forecasts, and other relevant compa

Tone
Positive 61/100
Event
Earnings
Published
25 Jun 2026 17:41
Source
TradingView
Sahm Direct company coverage

OPKO Health (OPK) Stock Could Be 57% Undervalued As Margin Recovery Comes Into Focus

OPKO Health (OPK) is currently trading at $1.46, with analysts suggesting it could be 57% undervalued, pointing to a fair value of $3.40. This valuation is based on expected margin recovery after the sale of BioReference's oncology assets, aiming for profitability in its Diagnost

Tone
Positive 65/100
Event
Earnings
Published
25 Jun 2026 09:40
Source
Sahm
Stock Titan Direct company coverage

OPKO HEALTH (OPK) director receives 80,000-share stock option grant

OPKO Health director Uppaluri Subbarao V received a grant of stock options for 80,000 shares as part of standard director compensation. These options have an exercise price of $1.42 per share, become exercisable on June 18, 2027, and expire on June 17, 2036. The grant involved ca

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 13:39
Source
Stock Titan
Stock Titan Direct company coverage

Director at OPKO (NASDAQ: OPK) receives grant of 60,000 stock options

OPKO Health, Inc. director Richard C. Pfenniger Jr. was granted 60,000 stock options with an exercise price of $1.42 per share. These options become exercisable on June 18, 2027, and expire on June 17, 2036. This transaction was reported via an SEC Form 4 filing, indicating an aw

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 01:40
Source
Stock Titan
Investing.com Nigeria Direct company coverage

Form 4 Opko Health For: 22 June By Investing.com

The article "Form 4 Opko Health For: 22 June" by Investing.com reports on a Form 4 filing for Opko Health (OPK) dated June 22, 2026. This brief piece, which appears to be a standard financial markets update, mentions the company's stock performance (+2.74%) and reiterates the For

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 01:10
Source
Investing.com Nigeria
Stock Titan Direct company coverage

Opko Health (OPK) director Roger Medel receives 30,000 stock options grant

Opko Health (OPK) director Roger Medel has been granted 30,000 stock options, with an exercise price of $1.42 per share. These options will become exercisable on June 18, 2027, and have an expiration date of June 17, 2036. This transaction is considered a grant or award of deriva

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 21:39
Source
Stock Titan
Stock Titan Direct company coverage

Opko Health (OPK) director awarded 30,000 stock options at $1.42 strike

OPKO Health director John A. Paganelli was granted 30,000 stock options at an exercise price of $1.42 per share as compensation. These options become exercisable on June 18, 2027, and will expire on June 17, 2036. Following this grant, Paganelli directly holds 30,000 options.

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 21:39
Source
Stock Titan
Stock Titan Direct company coverage

OPKO Health (OPK) director receives 30,000-share stock option award at $1.42

OPKO Health director Prem A. Lachman was granted options for 30,000 shares of common stock at an exercise price of $1.42 per share on June 18, 2026. This award is compensation-related, not an open-market transaction, and brings his directly held option position to 30,000 shares w

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 21:39
Source
Stock Titan
The Globe and Mail Direct company coverage

Opko Health Shareholders Back Board, Equity and Auditors

Opko Health shareholders re-elected all eleven nominees to the Board of Directors, approved the 2026 Equity Incentive Plan, and endorsed executive compensation at their Annual Meeting. They also ratified Ernst & Young LLP as the independent auditor. Despite weak financial perform

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 20:39
Source
The Globe and Mail